Biolife stock.

BioLife Solutions, Inc. (BLFS) Stock Price, Quote & News - Stock Analysis BioLife Solutions, Inc. ( BLFS) NASDAQ · USD 11.99 -0.06 (-0.50%) Oct 16, 2023, 10:35 …

Biolife stock. Things To Know About Biolife stock.

BLFE | Complete BioLife Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.WebBioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.WebDec 1, 2023 · Dividends. A high-level overview of BioLife Solutions, Inc. (BLFS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. BioLife Solutions, Inc. (Name of Issuer). Common Stock, $0.001 par value. (Title of Class of Securities) ...Four times named as one of the top 100 Companies to work for in Washington state (2022, 2020, 2015, and 2013), BioLife Solutions Inc. is a multi-platform provider of bioproduction tools and services to the cell and gene therapy and …

B. Riley FBR analyst Marc Wiesenberger resumed coverage of BioLife stock with a Buy rating and a price target of $27 per share, representing a 94.6% premium to Thursday's closing price. As cell ...Web

Biolife Solutions Inc (NASDAQ:BLFS) has a beta value of 1.60 and has seen 2.24 million shares traded in the last trading session. The company, currently valued at $596.91M, closed the last trade at $13.25 per share which meant it gained $0.88 on the day or 7.11% during that session. The BLFS stock ...Nov 30, 2023 · No changes to the price of Biolife Sciences Inc stock on the last trading day (Thursday, 30th Nov 2023). During the last trading day the stock fluctuated 100.00% from a day low at $0.0001 to a day high of $0.0002. The price has risen in 4 of the last 10 days and is up by 14900% over the past 2 weeks.

View the latest BioLife Sciences Inc. (BLFE) stock price, news, historical charts, analyst ratings and financial information from WSJ. Overview News BioLife Solutions Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.37 Market Cap 557.24 M …BioLife Solutions Inc (NASDAQ:BLFS). 12.77. Delayed Data. As of Nov 17. +0.81 / + ... Most stock quote data provided by BATS. Market indices are shown in real ...Aug 11, 2023 · The healthcare company's stock closed last week at $19.22, then dropped to a 52-week low of $11.82 on Friday. The stock is down more than 34% so far this year. ... So what. BioLife is a cell- and ...

BioLife Solutions (BLFS) (Delayed Data from NSDQ) $13.57 USD -0.06 (-0.44%) Updated Nov 22, 2023 03:59 PM ET After-Market: $13.55 -0.02 (-0.15%) 7:20 PM ET Add to portfolio Zacks Rank: 3-Hold 3...

BioLife Solutions Inc stock performance at a glance. Check BioLife Solutions Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.

BioLife Solutions Return On Equity is currently at (0.23)%. Return on Equity or ROE tells BioLife Solutions stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing BioLife Solutions profitability or the management effectiveness given the capital invested by the shareholders. ROE shows …Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to help you make ... Biolife Sciences Inc (BLFE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. BioLife Solutions Secures Equity Financing; Receives Research Grant; Provides Legal Update $1.38 Million in Financing; $177,000 from NIH; $1.6 Million Awarded in Court Decision BINGHAMTON, N.Y., De...Nov 9, 2023 · BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets. BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38 ...BioLife was founded as Trans Time Medical Products in 1987 and went public in 1989, raising net proceeds of $4.6 million at $105 per share (after giving effect to 1-for-five (2000) and 1-for-14 ...

BioLife Solutions, Inc. (“BioLife”, “us”, “we”, “our”, or the “Company”) is a developer, manufacturer, and supplier of a portfolio of bioproduction tools and services including proprietary biopreservation media, automated cell processing fill machines, closed system cryogenic vials, human platelet lysate (“hPL”) growth ...BioLife Solutions NasdaqCM:BLFS Stock Report Last Price US$12.37 Market Cap US$563.5m 7D -8.8% 1Y -43.4% Updated 30 Nov, 2023 Data Company …May 10, 2023 · BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ... Dec 18, 2022 · Conestoga Capital Advisors highlighted stocks like BioLife Solutions, Inc. (NASDAQ:BLFS) in its Q3 2022 investor letter. Headquartered in Bothell, Washington, BioLife Solutions, Inc. (NASDAQ:BLFS ... BioLife Solutions, Inc. : News, information and stories for BioLife Solutions, Inc. | Other OTC: | Other OTC

BioLife issued 6,646,870 shares of common stock in exchange for 100% of the outstanding shares of Stirling. BioLife management has provided guidance for Stirling's 2021 post-closing revenue contribution to be $35 million to $37 million , with total 2021 revenue of $101 million to $110 million .

Maxim Group analyst Jason McCarthy maintained a Buy rating on BioLife Solutions ( BLFS – Research Report) yesterday and set a price target of $30.00. The company’s shares opened today at $19. ...BioLife Solutions Inc stock performance at a glance. Check BioLife Solutions Inc’s past financial performance, like revenue or net income, plus the top level summary of its past …Biolife Stock Ipo: Can You Buy Stock In This Plasma Company? It’s a captivating David vs. Goliath story, where David — at least on some fronts — appears to be winning. When a stock goes ex-dividend, the value of that stock effectively falls by the dividend amount. This means if you hold a spread bet or CFD position on a company …BioLife Solutions, Inc. (BLFS) shares fell 3% during Thursday's session despite analysts continuing to back a turnaround from a fundamental perspective. B. Riley FBR analyst Marc Wiesenberger resumed coverage of BioLife stock with a Buy rating and a price target of $27 per share, representing a 94.6% premium to Thursday's closing …Nov 30, 2023 · No changes to the price of Biolife Sciences Inc stock on the last trading day (Thursday, 30th Nov 2023). During the last trading day the stock fluctuated 100.00% from a day low at $0.0001 to a day high of $0.0002. The price has risen in 4 of the last 10 days and is up by 14900% over the past 2 weeks. Discover Biolife from Goldwell. Within our collection of perming solutions from Goldwell, we stock the Biolife 2 Tinted/bleached hair solution, the Biolife 1 Normal/Fine solution and the Biolife Resistant / Coarse hair treatment. So whatever kind of hair your client has, be sure to have the perming solutions available for each and every variable!

BioLife Solutions Stock Up 7.1 %. Shares of NASDAQ BLFS opened at $13.25 on Monday. BioLife Solutions, Inc. has a one year low of $8.92 and a one year high of $26.89. The company has a debt-to ...

intraday 1w 1m 6m ytd 1y 3y 5y max Mountain-Chart Compare with Compare with up to 5 Stocks On Wednesday 11/08/2023 the closing price of the Biolife …

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced ...Posted 3:27:21 PM. By clicking the "Apply" button, I understand that my employment application process with Takeda…See this and similar jobs on LinkedIn.BioLife Solutions NasdaqCM:BLFS Stock Report Last Price US$12.37 Market Cap US$563.5m 7D -8.8% 1Y -43.4% Updated 30 Nov, 2023 Data Company …Aug 11, 2023 · The healthcare company's stock closed last week at $19.22, then dropped to a 52-week low of $11.82 on Friday. The stock is down more than 34% so far this year. ... So what. BioLife is a cell- and ... If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.The BioLife Solutions stock price gained 3.76% on the last trading day (Friday, 24th Nov 2023), rising from $13.57 to $14.08. During the last trading day the stock fluctuated 11.10% from a day low at $12.79 to a day high of $14.21. The price has risen in 6 of the last 10 days and is up by 23.62% over the past 2 weeks.Webintraday 1w 1m 6m ytd 1y 3y 5y max Mountain-Chart Compare with Compare with up to 5 Stocks On Wednesday 11/08/2023 the closing price of the Biolife …BioLife issued 6,646,870 shares of common stock in exchange for 100% of the outstanding shares of Stirling. BioLife management has provided guidance for Stirling's 2021 post-closing revenue contribution to be $35 million to $37 million , with total 2021 revenue of $101 million to $110 million .BOTHELL, Wash., July 27, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's second quarter financial results will be released after market close on Tuesday, August …BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38 ... Oral Biolife is an innovative biotechnology company out of Temple University that utilizes the unique properties of Piezo materials to develop groundbreaking, first-to-market products. Their lead ...

Stock analysis for BioLife Solutions Inc (BLFS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Biolife Solutions releases figures for Q3 on November 9. Wall Street analysts predict losses per share of $0.364. Go here to track Biolife Solutions stock price in real-time ahead of earnings.BioLife Solutions is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. Learn why I rate BLFS stock a hold.Stock Information; Investor Contact; Investor Contact. Media & Investor Relations: Troy Wichterman Chief Financial Officer (425) 402 - 1400 ... BioLife Solutions Inc. 3303 Monte Villa Parkway, Suite 310, Bothell, WA 98021 USA. T +1.866.424.6543 or 425.402.1400 F +1.425.402.1433 E [email protected]. NAVIGATION.WebInstagram:https://instagram. cornerstone total return fundiobtnvda earnings date 20231979 liberty silver dollar Biolife Sciences Inc (BLFE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Track Biolife Solutions Inc (BLFS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors wide moatdigital world acq news BioLife will issue 6,646,870 shares of common stock for 100% of the outstanding shares of Stirling in an all-stock transaction, which is expected to close early in the second quarter of 2021. With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted ...Casdin Capital now owns about 19.5% of BioLife Solutions' stock. BioLife Chief Financial Officer Troy Wichterman said the company didn't have any insight to provide beyond the publicly available ... forex broker metatrader 5 BioLife Solutions Price to Earnings To Growth is currently at 63.20 X. PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a …BIOLIFE4D IPO Registration Document (S-1) BIOLIFE4D has filed to go public with an IPO on the NASDAQ. 1 year ago - SEC. Get the latest BioLife4D Corporation (SAVU) stock price quote with news, financials, IPO details and other important investing information.